FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Major Pharmaceuticals Losartan Potassium Tablets Recall

Losartan Potassium Tablets, USP

MAJOR PHARMACEUTICALS · Livonia, MI

Risk level
Class II
Reported by FDA
Jul 17, 2019
Recall ID
D-1466-2019
Check your lot numberHow we source this data

Summary

Major Pharmaceuticals recalled Losartan Potassium Tablets starting Jan 10, 2019. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1466-2019 on Jul 17, 2019. Reason: CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer. Status: Terminated.

Why it was recalled

CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer

Product description

Losartan Potassium Tablets, USP. 50 mg. NDC# 0904-6390-61. Rx only. 100 count Unit Dose Cartons. Manufactured by Major Pharmaceuticals 17177 N. Laurel Park Drive Suite 233, Livonia, MI 48152.

Lot numbers, UPCs & expiration codes

Major Label Unit Does 10 x 10 Cartons, Major Item # 301835. Lot Number: R-00474. Expiration date: 07/2019.

Where it was sold

Nationwide.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1466-2019
Classification
Class II
Status
Terminated
Recall initiated
Jan 10, 2019
FDA report date
Jul 17, 2019
Quantity
3,102 Cartons (310,200 tablets)
Recalling firm
MAJOR PHARMACEUTICALS

Original FDA data

Every field from FDA enforcement report D-1466-2019, exactly as published.

Show all FDA fields
City
Livonia
State
MI
Status
Terminated
Country
United States
Event ID
83208
Address
17177 N Laurel Park Dr
Code information
Major Label Unit Does 10 x 10 Cartons, Major Item # 301835. Lot Number: R-00474. Expiration date: 07/2019.
Postal code
48152-2693
Report date
Jul 17, 2019
Product type
Drugs
Recall number
D-1466-2019
Classification
Class II
Recalling firm
MAJOR PHARMACEUTICALS
Product quantity
3,102 Cartons (310,200 tablets)
Termination date
Feb 19, 2023
Reason for recall
CGMP Deviations: FDA lab confirmed presence of an impurity, N-Methylnitrosobutyric acid (NMBA) in the finished product above the interim acceptable daily intake level at the manufacturer
Product description
Losartan Potassium Tablets, USP. 50 mg. NDC# 0904-6390-61. Rx only. 100 count Unit Dose Cartons. Manufactured by Major Pharmaceuticals 17177 N. Laurel Park Drive Suite 233, Livonia, MI 48152.
Distribution pattern
Nationwide.
Recall initiation date
Jan 10, 2019
Center classification date
Jul 9, 2019

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1466-2019, published Jul 17, 2019. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls